Publication:
Gingival Crevicular Fluid Levels of Sclerostin, Osteoprotegerin, and Receptor Activator of Nuclear Factor-kappa B Ligand in Periodontitis

Simple item page
dc.contributor.authorAydogdu, Ahmet
dc.contributor.authorBalli, UMUT
dc.contributor.authorDede, Figen Ongoz
dc.contributor.authorTurer, Cigdem Coskun
dc.contributor.authorGuven, Berrak
dc.contributor.institutionauthorBALLI, UMUT
dc.contributor.institutionauthorAYDOĞDU, AHMET
dc.date.accessioned2021-02-01T21:00:01Z
dc.date.available2021-02-01T21:00:01Z
dc.date.issued2015-12-01T00:00:00Z
dc.description.abstractBackground: To investigate changes in the levels and relative ratios of sclerostin, osteoprotegerin (OPG), and receptor activator of nuclear factor-kappa B ligand (RANKL) in the gingival crevicular fluid (GCF) of patients with periodontitis after non-surgical periodontal treatment.
dc.identifier.citationBalli U., Aydogdu A., Dede F. O. , Turer C. C. , Guven B., -Gingival Crevicular Fluid Levels of Sclerostin, Osteoprotegerin, and Receptor Activator of Nuclear Factor-kappa B Ligand in Periodontitis-, JOURNAL OF PERIODONTOLOGY, cilt.86, ss.1396-1404, 2015
dc.identifier.doi10.1902/jop.2015.150270
dc.identifier.scopus84958958297
dc.identifier.urihttp://hdl.handle.net/20.500.12645/28272
dc.identifier.wosWOS:000366044100011
dc.titleGingival Crevicular Fluid Levels of Sclerostin, Osteoprotegerin, and Receptor Activator of Nuclear Factor-kappa B Ligand in Periodontitis
dc.typeArticle
dspace.entity.typePublication
local.avesis.idf737b9c6-d62f-4104-a657-a15acf4c4b79
local.publication.isinternational1
relation.isAuthorOfPublication98da5869-ea4b-40c5-873f-9bbd29c50a23
relation.isAuthorOfPublication74d25d67-861e-495b-8d4f-a1ede52301cd
relation.isAuthorOfPublication.latestForDiscovery74d25d67-861e-495b-8d4f-a1ede52301cd

Files

Collections

Silinecekler